Follow Genmab A/S. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
13 Stories, 12 about Genmab A/S 91 approved Programs 3913 recruiting Registered trials Nov 10 Latest story
Timeline 12 Pipeline 9 Trials 39
Pipeline by stage
Approved 1 Phase 3 2 Phase 2 6
Details
Headquarters 1253 Copenhagen K, G7 Industry Pharmaceutical Preparations Also known as GMAB, GNMSF How the company describes itself Genmab develops antibody-based therapeutics including bispecific antibodies, antibody-drug conjugates, and immune-modulating antibodies for cancer and serious diseases. The Copenhagen-based company has eight approved medicines and a late-stage clinical pipeline. source